Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

Lorenzo Moja, Ersilia Lucenteforte, Koren H. Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F. Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L. SubramanianGianni Virgili

Research output: Contribution to journalReview article

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the systemic safety of intravitreal bevacizumab compared with intravitreal ranibizumab in people with neovascular AMD.

Original languageEnglish (US)
Article numberCD011230
JournalCochrane Database of Systematic Reviews
Volume2014
Issue number7
DOIs
StatePublished - Jul 24 2014

Fingerprint

Macular Degeneration
Safety
Ranibizumab
Bevacizumab

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Moja, L., Lucenteforte, E., Kwag, K. H., Bertele, V., Campomori, A., Chakravarthy, U., ... Virgili, G. (2014). Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews, 2014(7), [CD011230]. https://doi.org/10.1002/14651858.CD011230

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. / Moja, Lorenzo; Lucenteforte, Ersilia; Kwag, Koren H.; Bertele, Vittorio; Campomori, Annalisa; Chakravarthy, Usha; D'Amico, Roberto; Dickersin, Kay; Kodjikian, Laurent; Lindsley, Kristina; Loke, Yoon; Maguire, Maureen; Martin, Daniel F.; Mugelli, Alessandro; Mühlbauer, Bernd; Püntmann, Isabel; Reeves, Barnaby; Rogers, Chris; Schmucker, Christine; Subramanian, Manju L.; Virgili, Gianni.

In: Cochrane Database of Systematic Reviews, Vol. 2014, No. 7, CD011230, 24.07.2014.

Research output: Contribution to journalReview article

Moja, L, Lucenteforte, E, Kwag, KH, Bertele, V, Campomori, A, Chakravarthy, U, D'Amico, R, Dickersin, K, Kodjikian, L, Lindsley, K, Loke, Y, Maguire, M, Martin, DF, Mugelli, A, Mühlbauer, B, Püntmann, I, Reeves, B, Rogers, C, Schmucker, C, Subramanian, ML & Virgili, G 2014, 'Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration', Cochrane Database of Systematic Reviews, vol. 2014, no. 7, CD011230. https://doi.org/10.1002/14651858.CD011230
Moja, Lorenzo ; Lucenteforte, Ersilia ; Kwag, Koren H. ; Bertele, Vittorio ; Campomori, Annalisa ; Chakravarthy, Usha ; D'Amico, Roberto ; Dickersin, Kay ; Kodjikian, Laurent ; Lindsley, Kristina ; Loke, Yoon ; Maguire, Maureen ; Martin, Daniel F. ; Mugelli, Alessandro ; Mühlbauer, Bernd ; Püntmann, Isabel ; Reeves, Barnaby ; Rogers, Chris ; Schmucker, Christine ; Subramanian, Manju L. ; Virgili, Gianni. / Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. In: Cochrane Database of Systematic Reviews. 2014 ; Vol. 2014, No. 7.
@article{768dd2c25d1247f7b831b43ae8396f93,
title = "Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration",
abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the systemic safety of intravitreal bevacizumab compared with intravitreal ranibizumab in people with neovascular AMD.",
author = "Lorenzo Moja and Ersilia Lucenteforte and Kwag, {Koren H.} and Vittorio Bertele and Annalisa Campomori and Usha Chakravarthy and Roberto D'Amico and Kay Dickersin and Laurent Kodjikian and Kristina Lindsley and Yoon Loke and Maureen Maguire and Martin, {Daniel F.} and Alessandro Mugelli and Bernd M{\"u}hlbauer and Isabel P{\"u}ntmann and Barnaby Reeves and Chris Rogers and Christine Schmucker and Subramanian, {Manju L.} and Gianni Virgili",
year = "2014",
month = "7",
day = "24",
doi = "10.1002/14651858.CD011230",
language = "English (US)",
volume = "2014",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

AU - Moja, Lorenzo

AU - Lucenteforte, Ersilia

AU - Kwag, Koren H.

AU - Bertele, Vittorio

AU - Campomori, Annalisa

AU - Chakravarthy, Usha

AU - D'Amico, Roberto

AU - Dickersin, Kay

AU - Kodjikian, Laurent

AU - Lindsley, Kristina

AU - Loke, Yoon

AU - Maguire, Maureen

AU - Martin, Daniel F.

AU - Mugelli, Alessandro

AU - Mühlbauer, Bernd

AU - Püntmann, Isabel

AU - Reeves, Barnaby

AU - Rogers, Chris

AU - Schmucker, Christine

AU - Subramanian, Manju L.

AU - Virgili, Gianni

PY - 2014/7/24

Y1 - 2014/7/24

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the systemic safety of intravitreal bevacizumab compared with intravitreal ranibizumab in people with neovascular AMD.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the systemic safety of intravitreal bevacizumab compared with intravitreal ranibizumab in people with neovascular AMD.

UR - http://www.scopus.com/inward/record.url?scp=85041545101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041545101&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD011230

DO - 10.1002/14651858.CD011230

M3 - Review article

AN - SCOPUS:85041545101

VL - 2014

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 7

M1 - CD011230

ER -